Immune-boosting combo may shrink colorectal tumors before surgery
NCT ID NCT06154538
First seen Jan 06, 2026 · Last updated May 08, 2026 · Updated 22 times
Summary
This study tests whether adding immune checkpoint inhibitors to standard chemotherapy before surgery can better shrink or eliminate tumors in people with locally advanced colorectal cancer. About 170 adults aged 18 to 75 with stage II/III colorectal cancer will be randomly assigned to receive either the combination or chemotherapy alone. The main goal is to see if the combination leads to a higher rate of complete tumor disappearance at the time of surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital/ National Cancer Center, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100038, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250000, China
Contact
Contact
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, 510060, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.